Patent · US Active

Therapeutic heterocyclic compounds

US11186579B2 · kind B2 · utility

0Cited by

19References

36Claims

0Family size

Assignee

Gilead Sciences, Inc. · US

Inventors

Mark J. Bartlett · Castro Valley, US
Britton Kenneth Corkey · Redwood City, US
Kristyna M. Elbel · South San Francisco, US
Rao V. Kalla · Cupertino, US
Xiaofen Li · Thousand Oaks, US
Thao Perry · San Jose, US

Key dates

Filing date	Jul 3, 2019
Grant date	Nov 30, 2021
Priority date	—
Expiry date	Jul 3, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/519
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds having the following Formula (I), or a pharmaceutically acceptable salt or pharmaceutically acceptable tautomer thereof, and methods of their use and preparation are disclosed:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.